Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Total 13F shares
-
65,932,368
-
Share change
-
+1,429,976
-
Total reported value
-
$227,461,925
-
Price per share
-
$3.45
-
Number of holders
-
75
-
Value change
-
+$4,749,334
-
Number of buys
-
46
-
Number of sells
-
22
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2019
As of 31 Dec 2019,
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,932,368 shares.
The largest 10 holders included
Flagship Pioneering Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., ARK Investment Management LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.